“Harmless” Oral Microbe Can Enable Pathogen

By making oxygen more available, a benign bacterium can provide better growth conditions for a virulent one, according to a study.

Written byAlison F. Takemura
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, NIAIDA bacterium found in the healthy oral microbiome turns out to capable of unsavory behavior: abetting a pathogen. Researchers at the University of Texas (UT) at Austin reported last month (June 28) in mBio that Streptococcus gordonii provides oxygen to Aggregatibacter actinomycetemcomitans which can infect tooth, gum, and other tissues.

This is the first time a normally harmless mouth bacterium has been shown to change a pathogen’s metabolism to make the microbe more dangerous, Vanessa Sperandio of the UT Southwestern Medical Center in Dallas, who was not a part of the study, told Science News.

“Historically, we tend to think of infections as caused by a single organism, but many diseases are caused by multiple species,” Apollo Stacy, a graduate student who led the work, said in a statement.

Members of Stacy’s research group—in the UT lab of Marvin Whiteley—had previously observed the different bacteria cohabiting the same wounds, and that these species were intimately associated: S. gordonii fed A. actinomycetemcomitans with L-lactate, a carbon source the pathogen prefers.

But effective lactate respiration depends on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies